LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr. Lal PathLabs Ltd submitted its Q4 and full-year FY2026 financial results to NSE and BSE on May 1, 2026. The company published the results as newspaper advertisements in Financial Express and Jansatta on the same date, in compliance with SEBI Listing Regulations (Regulations 30 and 47). The filing is a disclosure submission rather than a direct earnings release, as the actual numbers are contained in the attached newspaper clippings. The letter was signed by Vinay Gujral, Company Secretary & Compliance Officer.
This filing is a procedural disclosure confirming the public dissemination of Q4 and FY2026 results. Investors should refer to the published newspaper ads or the company's earnings release for actual financial performance details. The stock may react based on the underlying numbers once market participants review them.